Literature DB >> 25610799

Non-invasive evaluation of culprit lesions by PET imaging: shifting the clinical paradigm away from resultant anatomy toward causative physiology.

Federico Caobelli1, Frank M Bengel1.   

Abstract

Although coronary angiography is the gold standard for assessing coronary artery disease (CAD), there is at best a weak correlation between degree of stenosis and the risk of developing cardiac events. Plaque rupture is the most common type of plaque complication, accounting for about 70% of fatal acute myocardial infarctions or sudden coronary deaths. Recently, the feasibility of (18)F-fluoride PET/CT in the evaluation of atherosclerotic lesions was assessed. Radionuclide techniques allow non-invasive biologic assessment of atherosclerotic plaques. This may help to further shift the clinical paradigm in coronary disease away from anatomy toward causative physiology and biology.

Entities:  

Keywords:  18F-fluoride PET/CT; 18F-fluorodeoxyglucose (18F-FDG) PET/CT culprit lesions; Atherosclerotic plaques; coronary artery disease (CAD); leukocyte scintigraphy

Year:  2014        PMID: 25610799      PMCID: PMC4278042          DOI: 10.3978/j.issn.2223-3652.2014.12.01

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  19 in total

1.  Relation of microchannel structure identified by optical coherence tomography to plaque vulnerability in patients with coronary artery disease.

Authors:  Hironori Kitabata; Atsushi Tanaka; Takashi Kubo; Shigeho Takarada; Manabu Kashiwagi; Hiroto Tsujioka; Hideyuki Ikejima; Akio Kuroi; Hideaki Kataiwa; Kohei Ishibashi; Kenichi Komukai; Takashi Tanimoto; Yasushi Ino; Kumiko Hirata; Nobuo Nakamura; Masato Mizukoshi; Toshio Imanishi; Takashi Akasaka
Journal:  Am J Cardiol       Date:  2010-06-15       Impact factor: 2.778

2.  Peptide receptor-targeted radionuclide therapy alters inflammation in atherosclerotic plaques.

Authors:  Imke Schatka; Tim Wollenweber; Cathleen Haense; Friederike Brunz; Klaus F Gratz; Frank M Bengel
Journal:  J Am Coll Cardiol       Date:  2013-09-25       Impact factor: 24.094

3.  IQ SPECT allows a significant reduction in administered dose and acquisition time for myocardial perfusion imaging: evidence from a phantom study.

Authors:  Federico Caobelli; Stefano Ren Kaiser; James T Thackeray; Frank M Bengel; Matteo Chieregato; Alberto Soffientini; Claudio Pizzocaro; Giordano Savelli; Marco Galelli; Ugo Paolo Guerra
Journal:  J Nucl Med       Date:  2014-11-20       Impact factor: 10.057

4.  Will the new advantages provided by PET in myocardial perfusion imaging help nuclear cardiology survive the test of time against conventional radiological techniques?

Authors:  Federico Caobelli; Davide Farina; Claudio Pizzocaro; Ugo Paolo Guerra
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-28       Impact factor: 9.236

5.  Evaluation of inflamed coronary atherosclerotic plaques by PET: more evidences for a promising area of cardiovascular imaging.

Authors:  Federico Caobelli
Journal:  J Nucl Cardiol       Date:  2014-05-24       Impact factor: 5.952

6.  (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.

Authors:  James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Ash Rafique; Michael Farkouh; Valentin Fuster; Zahi A Fayad
Journal:  J Am Coll Cardiol       Date:  2007-08-13       Impact factor: 24.094

7.  In vivo and in vitro evidence that ⁹⁹mTc-HYNIC-interleukin-2 is able to detect T lymphocytes in vulnerable atherosclerotic plaques of the carotid artery.

Authors:  Andor W J M Glaudemans; Elena Bonanno; Filippo Galli; Clark J Zeebregts; Erik F J de Vries; Michel Koole; Gert Luurtsema; Hendrikus H Boersma; Maurizio Taurino; Riemer H J A Slart; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-16       Impact factor: 9.236

Review 8.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

9.  In vivo imaging of enhanced leukocyte accumulation in atherosclerotic lesions in humans.

Authors:  Fleur M van der Valk; Jeffrey Kroon; Wouter V Potters; Rogier M Thurlings; Roelof J Bennink; Hein J Verberne; Aart J Nederveen; Max Nieuwdorp; Willem J M Mulder; Zahi A Fayad; Jaap D van Buul; Erik S G Stroes
Journal:  J Am Coll Cardiol       Date:  2014-09-09       Impact factor: 24.094

10.  Compared performance of high-sensitivity cameras dedicated to myocardial perfusion SPECT: a comprehensive analysis of phantom and human images.

Authors:  Laetitia Imbert; Sylvain Poussier; Philippe R Franken; Bernard Songy; Antoine Verger; Olivier Morel; Didier Wolf; Alain Noel; Gilles Karcher; Pierre-Yves Marie
Journal:  J Nucl Med       Date:  2012-11-08       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.